BioSpace News Archive

Business

Prothena Reports First Quarter 2023 Financial Results and Business Highlights

Prothena Corporation plc, a late-stage clinical biotechnology company with a robust pipeline of investigational therapeutics built on protein dysregulation expertise, reported financial results for the first quarter of 2023 and provided business highlights.

May 4, 2023
·
11 min read
Business

Mirum Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today reported financial results for first quarter 2023 and provided a business update.

May 4, 2023
·
9 min read
Biotech Bay

Silk Road Medical Announces Investor Education Webcast with Key Opinion Leaders

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced that the company will host an investor education webcast at 11:00 a.m. Eastern Time on Thursday, May 25, 2023.

May 4, 2023
·
1 min read
Bio NC

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - May 04, 2023

BioCryst Pharmaceuticals, Inc. announced that the compensation committee of BioCryst’s board of directors granted six newly-hired employees stock options to purchase an aggregate of 34,000 shares, and restricted stock units covering an aggregate of 23,800 shares, of BioCryst common stock.

May 4, 2023
·
1 min read
Business

Cognition Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

Cognition Therapeutics, Inc., a clinical-stage neuroscience company developing drugs that treat neurodegenerative disorders by regulating cellular damage response pathways, reported financial results for the first quarter ended March 31, 2023 and provided recent business updates.

May 4, 2023
·
8 min read
Business

Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2023 Financial Results

Avadel Pharmaceuticals plc, a biopharmaceutical company focused on transforming medicines to transform lives, provided a corporate update and announced its financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
14 min read
Business

89bio Reports First Quarter 2023 Financial Results and Provides Corporate Update

89bio, Inc., a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases, reported its financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
9 min read
Business

NextCure Provides Business Update and Reports First Quarter 2023 Financial Results

NextCure, Inc., a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer and other immune-related diseases provided a business update and reported first quarter 2023 financial results.

May 4, 2023
·
5 min read
Galmed Pharmaceuticals forms a Strategic Partnership with OnKai

Galmed Pharmaceuticals Ltd. reported the execution of a definitive agreement for a $3M equity investment in OnKai Inc., leading an investment round of $6M.

May 4, 2023
·
7 min read
Business

Curis Provides First Quarter 2023 Business Update

Curis, Inc., a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, reported its business update and financial results for the first quarter ended March 31, 2023.

May 4, 2023
·
12 min read